Does the Utilization of Allograft Tissue in Medial Patellofemoral Ligament Reconstruction in Pediatric and Adolescent Patients Restore Patellar Stability?

Abstract

Background

Medial patellofemoral ligament (MPFL) reconstruction is one of several surgical procedures used to treat patellofemoral instability. Use of allograft tissue can preserve autogenous tissue and may be preferable in patients with connective tissue disorders or ligamentous laxity. Although there are successful reports in adults, it is unclear if the use of allograft tissue in MPFL reconstruction can restore patellofemoral stability in children and adolescents.

Questions/purposes

(1) Does allograft tissue in MPFL reconstruction in pediatric and adolescent patients restore patellar stability? (2) What complications were associated with allograft MPFL reconstructions in children and adolescents?

Methods

Between June 2012 and August 2015, one surgeon (NKP) performed 26 MPFL reconstructions in 23 patients with gracilis allograft for traumatic patellar instability. Of those, 25 (96%) were available for followup more than 1 year later (mean, 24 months; range, 12–44 months). During this time, the surgeon suggested reconstruction to patients who had recurrent dislocation or subluxation after 6 weeks of bracing, physical therapy, and activity modification if they were noted to have a torn or attenuated MPFL on MRI. During that period, this was the only surgical technique the surgeon used to treat traumatic patellar instability. Patients undergoing concurrent bony procedures were ineligible for inclusion. The mean age of the patients in the series was 16.0 (± 2) years. Age, sex, skeletal maturity, presence of trochlear dysplasia, and additional arthroscopic procedures at the time of reconstruction were collected. Postoperative notes and imaging were reviewed for presence of complications defined as recurrent dislocation, recurrent subluxations, fractures, infection, or arthrofibrosis. These complications were identified by chart review by the senior surgeon (NKP) and study personnel (EH) not involved in clinical care of the patients or by patient-reported complications. Recurrent subluxation or dislocation was patient-reported at the time of the clinic visit or followup phone/email contact. Fractures were defined as any cortical disruption in the femur or patella that required treatment (change in postoperative protocol), infection requiring treatment (antibiotics and/or return to the operating room), or arthrofibrosis (stiffness that necessitated a change in the postoperative protocol or manipulation under anesthesia).

Results

Ninety-two percent (23 of 25) of patients reported no further instability episodes after MPFL reconstruction. Sixteen percent (four of 25) of patients had complications: two repeat episodes of patellar instability, one patella fracture, and one symptomatic hardware requiring interference screw removal. No patients developed arthrofibrosis or infection.

Conclusions

In this small case series, we found that MPFL reconstruction using allograft tissue in children and adolescents resulted in a low risk of recurrent instability, perhaps comparable to what has been published by others who have used autograft tissue. Longer followup is needed, because in some orthopaedic applications, allograft ligaments have been observed to attenuate over time. Future studies might compare these techniques using patient-reported outcomes scores as well as use a control group of patients with autograft tissue.

Level of Evidence

Level IV, therapeutic study.

Introduction

Patellar dislocations are among the most common knee injuries in the pediatric population [10, 16]. Unlike the adult population, the risk of recurrent instability is high [18]. Although the treatment of patients with first-time patellar dislocations remains controversial [39], recurrent dislocations in this population may benefit from surgical intervention. The medial patellofemoral ligament (MPFL) is the major medial soft tissue restraint that prevents lateral displacement of the patella during the first 30° of flexion [2] and is commonly injured after dislocation [3, 35]. Although primary repair of the MPFL has been reported to prevent recurrent patellar instability [43], there are also data to suggest a high risk of recurrent instability with this approach [22, 29]. MPFL reconstruction has been described as a successful treatment for preventing recurrent patellar instability in children and adolescents [11, 17, 21, 25–28, 31, 32, 46]. Redislocation is uncommon, occurring in between 0% and 20% of patients [21, 25, 32]. However, Parikh et al. [32] noted complications in 16.2% of patients including recurrent instability, patellar fractures, patellofemoral pain, and loss of flexion. Multiple techniques have been described for MPFL reconstruction in children and adolescents with both autograft and allograft tissue [1, 5, 8, 11, 12, 17, 21, 25–28, 30–33, 37, 40–42, 46]. Allograft tissue has potential advantages of limiting donor site morbidity including loss of strength, decreased surgical time, and use in patients with tissue disorders [4, 13, 20, 23, 24], yet it is important to note that these studies did not look at donor site morbidity from use of a single hamstring tendon (as opposed to a double hamstring harvest), which is used in MPFL reconstructions that theoretically may be less pronounced. In adults, allograft tissue has shown comparable results in regard to preventing recurrent patellar instability when used for MPFL reconstruction as compared with autograft [8, 45]. However, we are aware of only one report in children about allograft MPFL reconstructions [19]. Allograft reconstruction of the anterior cruciate ligament in active children and adolescents is associated with a higher risk of failure when compared with autograft [6, 9, 15], but it is unknown whether this risk applies to allograft MPFL reconstruction, because the forces this ligament experiences are different from those seen by the anterior cruciate ligament.

We therefore asked: (1) Does allograft tissue in MPFL reconstruction in pediatric and adolescent patients restore patellar stability? (2) What complications were associated with allograft MPFL reconstructions in children and adolescents?

Patients and Methods

Between June 2012 and August 2015 one surgeon (NKP) performed 26 MPFL reconstructions with gracilis allograft for patients with traumatic patellar instability. Of those, 25 (96%) were available for followup more than 1 year later (mean, 24 months; range, 12–44 months). During this time, the surgeon suggested reconstruction to patients who had recurrent dislocation or subluxation after 6 weeks of bracing, physical therapy, and activity modification, if they were noted to have a torn or attenuated MPFL on MRI. During that period, this was the only surgical technique the surgeon used to treat traumatic patellar instability. Patients were ineligible for inclusion if they had concomitant bony procedures including tibial tubercle transfers, osteotomies (for rotation or angular deformity), guided growth procedures, metabolic bone disease, neuromuscular disorders, or connective tissue disease. A minimum of 1 year of followup was required. In addition, they were excluded if they did not have preoperative MRI. Institutional review board approval was obtained for this retrospective study.

Twenty-three patients (three patients underwent bilateral surgery) met the initial inclusion criteria for the study representing 26 surgeries. One patient was lost to followup before the minimum of 1 year and so therefore was not included in the final analysis for a total of 25 patients. Patients who did not return for a scheduled visit after their 1-year followup were contacted by email or phone. All patients had some manner of followup within the last 2 years. Demographic data including age at time of surgery, sex, medical and surgical history, and affected extremity were collected. Preoperative radiographs and MRI were also evaluated in all patients. Skeletal maturity was assessed to determine if the physes were open or closed. MRIs were used to evaluate for the presence of trochlear dysplasia. Intraoperative images and operative notes were reviewed as well.

The mean age of patients was 16.0 (± 2) years with seven males and 18 females. Mean followup was 24 (± 10) months. No patients had a history or examination consistent with ligamentous laxity, 16 patients had closed physes at the time of surgery, and 21 patients presented with trochlear dysplasia. Fourteen patients required additional arthroscopic procedures at the time of MPFL reconstruction including chondroplasty of the femoral condyle or patella (nine), arthroscopic lateral release (five), loose body removal (three), patellar microfracture (one), partial lateral meniscectomy (one), and partial medial meniscectomy (one).

Surgical Technique

All patients first underwent a standard diagnostic arthroscopy to evaluate patellar tracking as well as additional intraarticular pathology. This was followed by open MPFL reconstruction. Using a medial parapatellar incision, the superomedial edge of the patella was exposed.

Under fluoroscopic guidance, taking care not to violate the articular surface of the patella, guide pins were placed across the patella, parallel to the joint line. The first was placed 3 mm distal to the superomedial corner of the patella and a second placed 10 to 15 mm distal and parallel to the first (Fig. 1). The guide pins were then overdrilled with a cannulated reamer taking care not to violate the far cortex. The thawed gracilis allograft was whipstitched 10 mm at each end using #2 braided nonabsorbable suture and secured into the patellar drill holes both proximally and distally with interference fixation. All grafts were obtained from Allosource (Centennial, CO, USA) and were frozen. The grafts were irradiated at a very low dose at the end of packaging to achieve the desired sterility level.

Fig. 1.

AP fluoroscopic image demonstrating patellar guide pin placement. The first was placed 3 mm distal to the superomedial corner of the patella and a second placed 10 to 15 mm distal and parallel to the first.

The femoral insertion site was then identified under fluoroscopic control as described by Schöttl et al. [34], and a guide pin was placed percutaneously at this site (Fig. 2). The guide pin was advanced across the femur bicortically and its position was confirmed radiographically making sure it did not cross the distal femoral physis. A 2- to 3-cm skin incision around the guide pin was made, and the guide pin was then overreamed with a reamer to the far cortex of the femur. In patients who were skeletally immature, both femoral guide pin placement and reaming were done under fluoroscopic guidance to ensure there was no physeal violation. Blunt dissection was then used to develop the interval between the capsule and the vastus medialis and the graft was passed from the patellar incision to the femoral incision. The graft was then passed into the femoral tunnel with the use of a passing suture around the looped gracilis graft, and the passing suture ends were delivered out the lateral skin. The graft was tensioned with the lateral patella flush with the lateral femoral condyle with the knee flexed at 30°, taking care to have equal tension on both graft ends. The isometry was then tested by cycling the knee through ROM. The graft was then fixed in place with a bioabsorbable screw (Fig. 3). Standard wound closure was performed and patients were discharged home with crutches and a ROM brace.

Fig. 2.

Lateral fluoroscopic imaging demonstrating the femoral guide pin insertion site.

Fig. 3.

Final lateral fluoroscopic imaging demonstrating fixation in the patella and femur after the graft has been secured.

Rehabilitation

All patients underwent a standard rehabilitation protocol. This included toe-touch weightbearing with crutches and a hinged knee brace locked in extension for 6 weeks postoperatively. Physical therapy was initiated 1 week postoperatively to begin knee ROM in the hinged knee brace. Knee ROM began at 0° to 30° and advanced to 0° to 90° by 6 weeks postoperatively. At 6 weeks postoperatively, the crutches and knee brace were discontinued. At 4 months after surgery patients were allowed to run and sporting activity was allowed at 6 months if patients demonstrated clinical stability. A graduated physical therapy program was used to allow return to sports. Patients were on average followed at 6-week intervals until 6 months after surgery and then 6 months after full return to sport.

Assessment of Endpoints

Postoperative notes and imaging were reviewed for presence of complications defined as recurrent dislocation, recurrent subluxations, fractures, infection, or arthrofibrosis. These complications were identified by chart review by the senior surgeon (NKP) and study personnel (EH) not involved in clinical care of the patients or through patient-reported complications by phone/email. Recurrent subluxation or dislocation was patient-reported at the time of the clinic visit and/or follow phone/email. Fractures were defined as any cortical disruption in the femur or patella that required treatment (change in postoperative protocol), infection requiring treatment (antibiotics and/or return to the operating room), or arthrofibrosis (stiffness that necessitated a change in the postoperative protocol or manipulation under anesthesia).

Results

Ninety-two percent (23 of 25) of patients reported no instability episodes at latest followup and had returned to their prior activity levels. Two patients sustained repeat dislocations, one who had trochlear dysplasia. No patients had recurrent subluxations.

Four of 25 patients (16%) developed postoperative complications. Two patients sustained repeat dislocations mentioned previously, one patient sustained a patella fracture as a result of a fall 6 months after surgery, and one patient underwent reoperation 17 months after surgery to remove a biointerference screw on the femoral side that was causing her irritation. No patients had an infection or developed arthrofibrosis.

Discussion

MPFL reconstruction is commonly used to treat patellofemoral instability both in children and adults. Allograft tissue can be used for ligament reconstruction, and although it has been noted to be used successfully in adults [8, 45], it is unclear if the use of allograft tissue in MPFL reconstruction will work as well in children. This of particular concern given the high risk of failure of allograft tissue in anterior cruciate ligament reconstruction in this population [6, 9, 15]. In a cohort of children and adolescents, we found that allograft MPFL reconstruction was associated with only an 8% rate of recurrent instability.

This study has a number of limitations. First, this was a relatively small sample size of patients without a control group of patients who underwent surgery with autograft tissue for comparison. Therefore, we cannot be certain whether this approach would be better or inferior to other approaches. Our study can be considered preliminary and may be used to help sample size calculations for future comparative trials between allograft MPFL reconstruction and other approaches; we believe such studies will be important in answering the questions posed in this article. Second, we did not collect patient-reported outcome scores. This is an important limitation, because without validated outcomes tools, our assessment is limited to the relatively basic endpoints of recurrent instability and major complications. Future studies on this topic should gather patient-reported outcome scores, because those will help us to compare this approach with other available options in a more nuanced manner, particularly as it relates to the preservation of autogenous tissue and postoperative pain and function. Future studies should also look at the specific risk factors for recurrent instability and will require multicenter efforts. Third, because allograft tissue can attenuate over time [7, 14], longer term followup of our patients will be important to ensure that these reconstructions remain durable in this population of young patients even given our mean followup of 2 years. Fourth, during this time period, not all patients underwent reconstruction for instability, which does represent a degree of patient selection bias, yet our indications were reasonable and consistent; the senior author (NKP) suggested reconstruction to patients who had recurrent dislocation or subluxation after 6 weeks of bracing, physical therapy, and activity modification, if they were noted to have a torn or attenuated MPFL on MRI. During that period, this was the only surgical technique the surgeon used to treat traumatic patellar instability. Finally, the risk of growth disturbance in performing the procedure is important for the clinician to consider. We had only nine patients with open physes at the time of the procedure with a mean age of the patients of 14 (± 2) years. Therefore, although these patients are skeletally immature, they represent a group that was nearing skeletal maturity. We also did not obtain long-standing films unless an abnormality was noted clinically as a result of the advanced age of the patients. No patients developed any clinically significant growth abnormalities (ie, leg length discrepancies or angular deformities). We do agree that a larger study with a much younger population of patients could address the risk of growth disturbance using this technique in a more skeletally immature population.

We found a low risk of repeat instability using allograft gracilis for MPFL reconstruction in children and adolescents with traumatic patellar instability, we believe comparable to other studies about allograft MPFL reconstructions in adults. In adults, Calvo Rodríguez et al. [8] compared 13 knees that underwent MPFL reconstruction with hamstring autograft versus 16 knees with allograft and found no recurrent dislocations in either group. Weinberger et al. [45] performed a systematic review comparing autograft and allograft and found no difference between either graft choice (recurrence rate of 5.7% for autograft and 6.7% for allograft) [45]. The observed risk of recurrence in our study seems similar to those of those other studies, which have examined allograft tissue in the adult population. Our results likewise seem similar to MPFL reconstruction with autogenous tissue in children and adolescents. Lind et al. [21] reported a 20% redislocation rate in their series of 20 children between the ages of 8 and 16 years with the utilization of autogenous tissue. Parikh et al. [32] in a series of 179 knees found a redislocation rate of 4.6%, and Nelitz et al. [25] in their series of 21 knees had a 9.5% rate of continued apprehension after reconstruction with autogenous tissue. Even in the context of trochlear dysplasia (present in 21 of our 25 knees), which places additional strain on the MPFL as a result of lack of bony constraint, our recurrence rates were low. Only one of our patients with a recurrence had trochlear dysplasia. Other authors have reported a correlation between worse outcomes and degree of trochlear dysplasia after MPFL reconstruction [36, 44]. However, because allograft tissue can attenuate over time [7, 14], longer term followup of our patients will be important to ensure that these reconstructions remain durable in this population of young patients.

The use of allograft tissue in our study resulted in an overall complication rate of 16%, which seems similar to what has been reported for both autogenous and allograft tissue in adults as well as autograft tissue in the pediatric and adolescent populations. Calvo Rodríguez et al. [8] noted complications in 19% of adults treated with allograft tissue, including one revision procedure resulting from poor anchor placement, one patellar fracture, and one patient who developed postoperative arthrofibrosis. Singhal et al. [38] examined nine different studies representing 320 MPFL reconstructions done with hamstring autograft and found a complication rate of 12.5%, including cases of arthrofibrosis and patellar fracture. In the pediatric and adolescent populations, Parikh et al. [32] noted an overall complication rate of 16.2% including eight cases of arthrofibrosis, six patellar fractures, and five cases of prolonged pain. As a result, taking overall complication rate into consideration, allograft tissue utilization in our study was similar to what has been reported for autograft and allograft in adults as well as autograft in pediatric patients. It is important to note that all allografts are not equivalent and that preparation differences may make historical allograft literature less applicable than the historical autograft literature. It is also important to note that rehabilitation protocols differed not only between these studies, but also with the protocol used at our institution. This can be a factor that accounts for the difference in the incidence of complications between the different papers.

In this small case series, we found that MPFL reconstruction using allograft tissue in children and adolescents resulted in a low risk of recurrent instability, perhaps comparable to what has been published by others who have used autograft tissue. Longer followup is needed, because in some orthopaedic applications, allograft ligaments have been observed to attenuate over time [7, 14]. Future studies will be performed with a control group of patients using autogenous tissue with patient-reported outcomes to further understand graft choice in the pediatric and adolescent populations.